Ypsomed Holding AG (XSWX:YPSN) EPS without NRI: CHF10.00 (TTM As of Mar. 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF357.00
GF Value CHF396.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG EPS without NRI?

Ypsomed Holding AG XSWX:YPSN -0.67% 92 EPS without NRI is CHF10.00 as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF396.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 664 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 92.77% on this metric.

Ypsomed Holding AG's earnings per share without non-recurring items for the six months ended in Mar. 2026 was CHF6.11. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was CHF10.00.

During the past 12 months, Ypsomed Holding AG's average earnings per share (NRI) Growth Rate was 154.30% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 62.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 106.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Ypsomed Holding AG's EPS without NRI or its related term are showing as below:

XSWX:YPSN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -89.9   Med: 25.85   Max: 191.8
Current: 62.2

During the past 13 years, Ypsomed Holding AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 191.80% per year. The lowest was -89.90% per year. And the median was 25.85% per year.

XSWX:YPSN's 3-Year EPS without NRI Growth Rate is ranked better than
92.77% of 664 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs XSWX:YPSN: 62.20

Ypsomed Holding AG's EPS (Diluted) for the six months ended in Mar. 2026 was CHF6.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF16.30.

Ypsomed Holding AG's EPS (Basic) for the six months ended in Mar. 2026 was CHF6.12. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF16.31.


Ypsomed Holding AG  (XSWX:YPSN) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ypsomed Holding AG EPS without NRI Related Terms


Ypsomed Holding AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG EPS without NRI Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 3.82 5.74 6.41 16.30

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.06 2.39 4.02 3.89 6.11

XSWX:YPSN vs ISRG, BDX, MDLN: EPS without NRI Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's PE Ratio without NRI falls into.


XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF10.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of CHF10.00 mean?
Ypsomed Holding AG (XSWX:YPSN) has a EPS without NRI of CHF10.00 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #48 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 7.2%.
Is Ypsomed Holding AG's EPS without NRI too high?
Ypsomed Holding AG's current EPS without NRI is CHF10.00. Based on the distribution chart, Ypsomed Holding AG ranks #48 out of 664 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #48 out of 664 companies for EPS without NRI. This places Ypsomed Holding AG in the top 7% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current EPS without NRI is CHF10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF396.98, compared to a current price of CHF357.00 — trading 10.1% below its estimated fair value. The current EPS without NRI is CHF10.00. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current EPS without NRI is CHF10.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF357.00 is trading 10.1% below its estimated GF Value™ of CHF396.98. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

  • EPS without NRI: CHF10.00
  • GF Value™: CHF396.98 vs. price of CHF357.00 (10.1% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF357.00
Price
CHF396.98
GF Value